[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@WallStSai Avatar @WallStSai S A I ™️

S A I ™️ posts on X about $xbi, $vktx, $mdgl, $abvx the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX% finance XXXXX% currencies #2530 technology brands XXXX% social networks XXXX% cryptocurrencies XXXX% travel destinations XXXX%

Social topic influence $xbi #6, $vktx #9, $mdgl #2, $abvx #5, $gpcr #6, $lly #8, $bmy #12, $nvo #36, $mrk #44, $azn #5

Top accounts mentioned or mentioned by @bioinvestor24 @doepkemichel @askfinvest @pjamess69 @stockgutter @phoenix3million @doodaddoctor @andre_agtc @pickingmyown @troytiger @aggregategains @pacha_8x @seekingalpha @pcmbio @andybradley93 @mitchmartan98 @maziardoustdar @bavariaron @tbbtrades @lelounge

Top assets mentioned Viking Therapeutics, Inc (VKTX) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Eli Lilly and Company (LLY) Bristol-Myers Squibb Co (BMY) Novo-Nordisk (NVO) Merck & Co., Inc. (MRK) AstraZeneca PLC (AZN) Viking Holdings Ltd (VIK) Pfizer, Inc. (PFE) Cidara Therapeutics, Inc. (CDTX) Metsera, Inc. Common Stock (MTSR) Gilead Sciences, Inc. (GILD) AltLayer (ALT) Protagonist Therapeutics, Inc (PTGX) Synthetify (SNY) AbbVie Inc (ABBV) Intra-Cellular Therapies Inc. (ITCI) BridgeBio Pharma, Inc. Common Stock (BBIO) Cytokinetics Inc. (CYTK) TG Therapeutics, Inc. (TGTX) Axsome Therapeutics, Inc (AXSM) Novartis AG (NVS) GSK plc (GSK) Johnson & Johnson (JNJ) Shopify Inc (SHOP) Exact Sciences Corp (EXAS) Arcblock (ABT) The Official XX Coin (67) Goldman Sachs (GS)

Top Social Posts

Top posts by engagements in the last XX hours

"$MDGL Big Jan2026 XXX Call Buyer for $800K"
X Link 2025-11-11T20:49Z 7796 followers, 6450 engagements

"$BMY I am predicting Bristol Myers will make a HUGE acquisition of $15B+ size very soon. Lots of setbacks to the company just recently. Time is running out for them $XBI $MDGL $ABVX $VKTX $PTGX"
X Link 2025-11-23T21:09Z 7796 followers, 15.6K engagements

"$BMY has $XXXX Billion Cash on Hand and $MDGL Madrigal is a good Bolt-On acquisition target which may fetch $4-$5 billion in revenues by 2029 timeframe"
X Link 2025-11-24T15:06Z 7796 followers, 5062 engagements

"$MDGL New XX Week High"
X Link 2025-11-24T20:39Z 7796 followers, 4367 engagements

"$MDGL Strong Volumes last X trading sessions. Stock making new all time high today. Way to Go Madrigal"
X Link 2025-11-24T22:51Z 7796 followers, 9692 engagements

"$MDGL Options IV is raising Looks like $XXX test will come today 🤞🏼"
X Link 2025-11-25T19:55Z 7796 followers, 7617 engagements

"@PCM_bio $MDGL is a perfect choice for $BMY"
X Link 2025-11-25T20:53Z 7796 followers, XXX engagements

"@doepke_michel Oh how about $MDGL"
X Link 2025-11-26T10:46Z 7796 followers, XXX engagements

"@AndyBradley93 @doepke_michel $MDGL may come in early"
X Link 2025-11-26T10:46Z 7796 followers, XXX engagements

"@MitchMartan98 $MDGL is a commercial biotech company already hit sales runrate of $1B + and buyout target as well. Lot more room higher IMHO"
X Link 2025-11-26T14:15Z 7796 followers, XXX engagements

"@bioinvestor24 $BMY should acquire $MDGL or $VKTX for company to fall in place in line with $MRK"
X Link 2025-11-30T18:30Z 7796 followers, XXX engagements

"$MDGL Mardi Dier CFO of Madrigal Pharmaceuticals spotlights the company's latest quarter and the launch of their first product. She talks about Madrigal's drug sales the company's balance sheet international expansion and an extended patent. $XBI"
X Link 2025-12-04T22:43Z 7796 followers, 3392 engagements

"$XBI This bidding process clearly shows how desperate big pharma is right now to replace LOEs and Patent Expirations. If you put away $MRK there are still five different big pharma companies who participated in a bid to acquire $CDTX. They all should have decent M&A fire power and may acquire other smaller biotech companies down the line in a short timeframe. Just recently biotech sector witnessed bidding war between $PFE and $NVO to acquire $MTSR The annual J.P. Morgan Healthcare Conference (JPM) served as a powerful catalyst for Mergers and Acquisitions (M&A) activity in the biotech sector"
X Link 2025-12-06T03:11Z 7796 followers, 6350 engagements

"@bioinvestor24 $ITCI also presented at JPM this year but got bought out just a day before JPM conference has started. So no big deal we can get acquired anytime. $MDGL is my hot favorite for buyout now"
X Link 2025-12-10T00:23Z 7796 followers, XXX engagements

"$MDGL Rezdiffra working wonders for F4 patients too. Very Impressive. Looks like company already has captured required safety and tolerability data points to apply for F4 label expansion. F4 MASH cirrhosis could be a huge growth driver for Madrigal if approved. $XBI"
X Link 2025-11-25T01:26Z 7809 followers, 8611 engagements

"$PFE Pfizer Enters Into Exclusive Collaboration And License Agreement With Yaopharma For The Development Manufacturing And Commercialization Of YP05002 A Small GLP-1 Molecule Currently In Phase X Development For Chronic Weight Management $XBI $VKTX $LLY $NVO $MTSR $GPCR"
X Link 2025-12-09T11:55Z 7810 followers, 6180 engagements

"$MDGL Hot M&A Buyout Target for Big Pharma Baker will atleast look for $18-$20 billion premium $XBI $BMY $GILD $LLY"
X Link 2025-12-11T18:59Z 7809 followers, 4828 engagements

"$XBI $MDGL $ABVX $VKTX $BBIO $CYTK $TGTX $AXSM Some Hot M&A Targets for Big Pharma"
X Link 2025-12-12T14:46Z 7810 followers, 7210 engagements

"$ABVX Who will be the Bidding War Winner $AZN or $JNJ or $LLY"
X Link 2025-12-12T20:47Z 7810 followers, 3606 engagements

"$SHOP had $7.8B in cash at the end of Q1. $STMP under contract to be bought for $6.6B. Contract includes a XX day period for other offers. $SHOP could offer a buyout at $XXX / share and still have cash leftover (if they offered all cash)"
X Link 2021-07-19T20:05Z 7795 followers, XX engagements

"$ABVX Its pretty normal for any pre commercial company to have very minimal to no hiring. Hiring doesnt matter for M&A. Look $EXAS Exact Sciences has 100+ job openings even today after $ABT Abbotts $20B+ acquisition"
X Link 2025-11-23T22:19Z 7796 followers, 4001 engagements

"$VKTX stock is very cheap at XX. It has both MASH plus Obesity assets also CEO recently said open to partnerships or BD. Good chance of M&A possible by JPM conference in January $XBI"
X Link 2025-11-26T16:14Z 7803 followers, 11.4K engagements

"$VKTX Viking options flow also gets interesting at the same time with ITM Dec5 XX strike calls being bought aggresively with one week to expiration. Looks like players betting on weak $GPCR GLP-1 data read and at the same time expects data by 12/19 options expiration"
X Link 2025-11-29T14:47Z 7803 followers, 17.4K engagements

"@bioinvestor24 I see what you say some big bio hedge funds have a small size position in $GPCR but not significant size"
X Link 2025-11-29T15:08Z 7798 followers, 1164 engagements

"$ALT ALTIMMUNE CEO TO STEP DOWN EFFECTIVE JAN X PEMVIDUTIDE 48WK MASH DATA DUE Q4 2025"
X Link 2025-12-01T13:33Z 7802 followers, 1511 engagements

"$MRK $XBI MERCK LOOKS TO RAISE UP TO $X BILLION FROM US DOLLAR BOND SALE"
X Link 2025-12-01T14:48Z 7797 followers, 7710 engagements

"$BMY Bristol Myers must face $XXX billion lawsuit over delayed cancer drug US judge rules Bristol Myers accused of delaying FDA approvals for three drugs Lawsuit linked to $XXXX billion Celgene acquisition"
X Link 2025-12-02T03:26Z 7798 followers, 42.6K engagements

"@_le_Lounge $VKTX should get atleast $10-$12B on a buyout"
X Link 2025-12-02T05:16Z 7803 followers, XXX engagements

"@bioinvestor24 $MRK may also hunt for $VKTX Exciting times lol 😂"
X Link 2025-12-02T19:40Z 7803 followers, XXX engagements

"$GPCR GLP-1 data any day now"
X Link 2025-12-02T20:04Z 7799 followers, 2911 engagements

"$XBI Why $NVO Novo Nordisk may look to acquire $VKTX Viking Therapeutics $NVO Novo is aggressively pursuing M&A after losing the $MTSR Metsera bid and needs a dual-agonist to compete with $LLY Eli Lilly 🔹 Dual Agonism (GLP-1/GIP) $NVO Novo Nordisk's current successful drugs (Wegovy Ozempic) are single GLP-1 agonists. $VKTX Viking's VK2735 is a dual GLP-1/GIP agonist the same mechanism as Eli Lilly's Zepbound/Mounjaro which has shown highly competitive efficacy data. Acquiring $VKTX would immediately provide $NVO Novo Nordisk with a powerful next-generation dual-action molecule to compete"
X Link 2025-12-03T06:39Z 7796 followers, 46K engagements

"@doepke_michel $VKTX has a good chance"
X Link 2025-12-03T16:46Z 7804 followers, XXX engagements

"$ABBV Abbvie CFO says they will continue to look for M&A transactions in obesity space and they are not finished with Gubra transaction $XBI $VKTX $LLY $NVO $GPCR"
X Link 2025-12-03T17:01Z 7796 followers, 9313 engagements

"$GPCR April 2026 XX strike puts bought for $182k Data release should be just around the corner in next few days"
X Link 2025-12-03T20:20Z 7796 followers, 2727 engagements

"@ResearchPulse1 @Pharmdca It wont be an issue. $PFE put in pressure using political influence on FTC. $NVO will not have any issues acquiring $VKTX as it has got multiple items in their pipeline like MASH and XAD as well apart from GLP1. Why only buyout Why not partnerships"
X Link 2025-12-03T21:49Z 7803 followers, XXX engagements

"@bioinvestor24 So FDA should allow $VKTX to move to ph3 right"
X Link 2025-12-04T04:03Z 7800 followers, 1216 engagements

"$VKTX There is that squeeze Flow speaks. Buyout Rumors"
X Link 2025-12-04T15:20Z 7800 followers, 26.2K engagements

"Did $NVO CEO see this 🤨 $VKTX"
X Link 2025-12-04T15:45Z 7797 followers, 6718 engagements

"$VKTX Viking Therapeutics features on CNBC Fast money segment for about three minutes. Basically they said todays ruling by FDA is a fast track for $VKTX allows them to ramp up the drug approval process $XBI"
X Link 2025-12-04T23:25Z 7804 followers, 13K engagements

"Looks like $GPCR GLP-1 data release is imminent on monday. Lots of options positioning today. $XBI $VKTX $LLY $NVO"
X Link 2025-12-05T16:23Z 7799 followers, 14.6K engagements

"$GPCR GLP-1 36wk ph2b $ALT MASH 48wk ph2 $XBI data on deck next week possibly which ones will succeed/fail Also M&A weekend time Bring those deal rumors back on Lot of M&A firepower with big pharma especially $BMY $AZN $GILD $MRK $PFE"
X Link 2025-12-05T20:01Z 7799 followers, 4634 engagements

"$ABVX Who will it be $AZN or $SNY"
X Link 2025-12-08T20:19Z 7798 followers, 5284 engagements

"$AZN Aggresive Dec19 XXXX puts bought into close $ABVX M&A deal on cards"
X Link 2025-12-08T20:37Z 7798 followers, 8907 engagements

"@mroliverbarnes Brother I certainly assume FT biotech M&A scoop is already in works 😀 European company and hope you are on top of the coverage 👍🏼 $ABVX $AZN"
X Link 2025-12-08T23:43Z 7796 followers, 4849 engagements

"$ABVX Now they have added Dec19 XXX calls for 400k with one week to expiration"
X Link 2025-12-09T15:05Z 7798 followers, 17.2K engagements

"Looks like $ABVX not presenting at JPM"
X Link 2025-12-09T23:31Z 7803 followers, 11.1K engagements

"@A_May_MD Adam - You are absolutely right You have a very valid point. Who will just throw away $4M in OTM options calls that too $XX away current stock price strikes that too just one week to expiration Very obvious its a buyout positioning just before the deal gets announced"
X Link 2025-12-10T00:57Z 7796 followers, XXX engagements

"@Phoenix3million Really Why did $MRK pay XXX% premium for $CDTX"
X Link 2025-12-10T01:23Z 7796 followers, XXX engagements

"@adamfeuerstein So should we wait till Goldman Sachs conference for buyout 😜"
X Link 2025-12-10T01:29Z 7796 followers, 1198 engagements

"$CDTX Big Options flow detected on 11/10 and Buyout deal announced 11/14. Unusual Flow always knows $ABVX Options flow is also in the same boat. With no catalysts events presentations and data who would buy deep OTM calls worth $4M expiring in one week"
X Link 2025-12-10T01:47Z 7796 followers, 6523 engagements

"$ABVX ABIVAX POPS XX% ON MARKET TALK ABOUT $LLY ELI LILLY TAKEOVER INTEREST - REUTERS Two traders citing market speculation about potential takeover interest from Eli Lilly. Abivax and Eli Lilly were not immediately available for comment"
X Link 2025-12-10T10:07Z 7798 followers, 7882 engagements

"$LLY ELI LILLY'S TRIPLE AGONIST RETATRUTIDE DELIVERED WEIGHT LOSS OF UP TO AN AVERAGE OF XXXX LBS ALONG WITH SUBSTANTIAL RELIEF FROM OSTEOARTHRITIS PAIN IN FIRST SUCCESSFUL PHASE X TRIAL $XBI $NVO $GPCR $VKTX $ABBV"
X Link 2025-12-11T11:51Z 7803 followers, 11K engagements

"@bioinvestor24 Anything is possible with this kind of biotech M&A market. Bidding wars etc. $MDGL analysts anticipate $6-$7 B peak revenues so $20B is a very decent ask"
X Link 2025-12-11T19:14Z 7798 followers, XXX engagements

"$ALT MASH data release looks imminent this week"
X Link 2025-12-08T19:38Z 7804 followers, 2389 engagements

"$ABVX CEO Marc de Garidel is good at making M&A deals he led two biotech deals below. At the same time he worked for $LLY Eli Lilly as well 🔹 Sale of CinCor Pharma to AstraZeneca. 🔹 Sale of Corvidia Therapeutics to Novo Nordisk"
X Link 2025-12-10T04:08Z 7810 followers, 7856 engagements

"@monaco_biotech $ABVX You should understand the amount of options premiums on 160/180/190 strikes expiring next week is very significant totaling more than $X million. Most of these options contracts were opened last week"
X Link 2025-12-13T13:55Z 7810 followers, XXX engagements